Israel-based LabStyle Innovations, which is developing a smartphone-based glucose meter, has raised $10 million by common stock that the company plans to accredited investors. The company plans to use the money to develop, market and manufacture Dario, its smartphone-enabled diabetes management system. Dario does not have a CE mark nor does it have FDA approval. LabStyle CEO Dr. Oren Fuerst aims...